tirzepatide triple agonist Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Transforming obesity: The advancement of
Description
Researchers also are finding that GLP-1 drugs help with other health problems, including reducing liver diseases
Tell your doctor if you plan to become pregnant, are pregnant, or are breastfeeding
Replacement of the C-terminal Trp-cage of exendin-4 with a fatty acid improves therapeutic utility
6 MAR709 had finished its Phase 2a clinical trial in 2017, 51 and it is a balanced dual agonist for GLP-1R and GIPR
Even Phe could be considered as a potential replacement, and Lys from exenatide/CY-5 also seems feasible
